Mesothelioma Vaccine Development
Gene therapy of mesothelioma reviewed
Published in Gene Therapy Weekly, October 20th, 2005
According to a study from Australia, "Despite improved diagnostic skills and new chemotherapeutic regimens, malignant mesothelioma (MM) remains a pathological disease with survival expectations after diagnosis remaining <1 year. As the incidence of this disease has yet to peak, there is a pressing need for new therapeutic approaches. One such approach is gene therapy, which inserts 'therapeutic' genes into (generally) tumor cells seeking to induce tumor regression via a number of different theoretical mechanisms."
"This approach may be...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-10-20)
More Articles from Gene Therapy Weekly
- DNA Vaccine
Characteristics of nanoparticles for gene delivery outlined - Enzymology
Derivatives of DNA-modifying enzymes function as targeting tools - Hypertension
Gene therapy to be used to lower blood pressure - Acute Myeloid Leukemia
BMI-1 is highly expressed in MO-subtype acute myeloid leukemia - Acute Myeloid Leukemia
New findings in the area of acute myeloid leukemia described - Allergy Medicine
T cells induced by Foxp3-retrovirus infection control contact allergy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
